Glioblastoma Multiforme Treatment Market Worth $4.2 Billion By 2028
Glioblastoma Multiforme Treatment Industry Overview The global glioblastoma multiforme treatment market size is expected to reach USD 4.2 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 8.8% from 2021 to 2028. The market is driven by the rising prevalence of the disease and increasing approval for novel therapy and combination therapy. Glioblastoma Multiforme Treatment Market Segmentation Grand View Research has segmented the global glioblastoma multiforme treatment market on the basis of treatment, drug class, end-use, and region: Based on the Treatment Insights, the market is segmented into Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy, Tumor Treating Field (TTF) Therapy, Immunotherapy. Radiation therapy dominated the market with a revenue share of 37.6% in 2020 owing to the improved survival rates. Radiation therapy can be recommended as the first treatment or combined with chemotherapy ...